Insulet
PODD
#1049
Rank
A$32.26 B
Marketcap
A$458.41
Share price
-3.62%
Change (1 day)
10.50%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of September 2025 : A$1.52 Billion

According to Insulet's latest financial reports the company's total debt is A$1.52 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$2.23 B7.7%
2023-12-31A$2.07 B0.88%
2022-12-31A$2.05 B17.23%
2021-12-31A$1.75 B27.55%
2020-12-31A$1.37 B8.63%
2019-12-31A$1.26 B50.91%
2018-12-31A$0.84 B15.88%
2017-12-31A$0.72 B57.09%
2016-12-31A$0.46 B89.48%
2015-12-31A$0.24 B17.52%
2014-12-31A$0.20 B51.97%
2013-12-31A$0.13 B19.97%
2012-12-31A$0.11 B7.41%
2011-12-31A$0.10 B54.86%
2010-12-31A$68.35 M-36.68%
2009-12-31A$0.10 B26.58%
2008-12-31A$85.28 M179.51%
2007-12-31A$30.51 M-17.69%
2006-12-31A$37.06 M177.31%
2005-12-31A$13.36 M93940.35%
2004-12-31A$0.01 M-3.95%
2003-12-31A$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ICU Medical
ICUI
A$2.05 B 34.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
A$0.67 B-55.73%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$3.87 B 153.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 4,412.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$19.48 B 1,175.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$43.07 B 2,719.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$63.99 B 4,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA